Skip to main content
Clinical Trials/CTRI/2024/04/065327
CTRI/2024/04/065327
Not yet recruiting
Phase 2

Comparison of best supportive care with or without topicalautologous platelet rich plasma as a prophylactic agent for reducing acute radiation dermatitis: a randomized controlled study. - NI

Dr. Ebenezer Staines0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C50-C50- Malignant neoplasms of breastHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Sponsor
Dr. Ebenezer Staines
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr. Ebenezer Staines

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients over 18 years of age.
  • 2\. Patients of ECOG performance status 0\-2
  • 3\. Patients with biopsy proven squamous cell
  • carcinoma of the head and neck, receiving curative
  • radiation with or without concurrent chemotherapy
  • in the definitive or adjuvant setting.
  • 4\. Patients with biopsy proven adenocarcinoma of the breast, post\-surgical resection (either breast
  • conservative surgery or modified radical
  • mastectomy) who are receiving curative radiation in the adjuvant setting.

Exclusion Criteria

  • 1\. Patients receiving palliative radiation
  • 2\. Patients with prior history of radiation to the head and neck or breast
  • 3\. Patients with tumor involving the skin
  • 4\. Patients with rash, ulceration or open wounds in the treatment field.
  • 5\. Patients too sick to withstand a blood withdrawal of more than 100 ml e.g., those with multiple comorbidities like cardiac diseases, respiratory diseases etc (to be decided by the clinical judgment of the physician in the Blood bank/ Transfusion medicine center )

Outcomes

Primary Outcomes

Not specified

Similar Trials